Involvement of TRAIL/TRAIL-R interaction in IFN-α-induced apoptosis of Daudi B lymphoma cells

Cytokine

Volumn 14, Issue 4, 2001, Pages 193-201

  Oshima, Kazutaka ^a   Yanase, Noriko ^a   Ibukiyama, Chiharu ^a   Yamashina, Akira ^a   Kayagaki, Nobuhiko ^b   Yagita, Hideo ^b   Mizuguchi, Junichiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Apoptosis; IFN ; TRAIL; Tumour

Indexed keywords

ALPHA INTERFERON; CYTOKINE RECEPTOR; FAS ANTIGEN; NEUTRALIZING ANTIBODY; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; CYTOTOXICITY; DAUDI CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; TUMOR;

EID: 0035926316     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2001.0873     Document Type: Article

References (57)

1. Wherefore interferon?
2. Cytokine therapeutics: Lessons from interferon α
3. Cytokine research: The interferon paradigm
4. Changes of cell cycle-regulating genes in interferon-treated Daudi cells
5. Regulation of the product of a possible human cell cycle control gene CDC2Hs in B-cells by α-interferon and phorbol ester
6. Interferon α induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: Role in growth regulation
7. Induction of apoptosis and inhibition of cell growth are independent responses to Interferon-α in hematopoietic cell lines
8. Participation of Bax-alpha in IFN-alpha-mediated apoptosis in Daudi B lymphoma cells
9. Cytochrome c release, mitochondrial membrane depolarization, caspase-3 activation, and bax-alpha cleavage during IFN-alpha-induced apoptosis in daudi B lymphoma cells
10. Cytochrome c: Can't live with it-can't live without it
11. Mitochondria as regulators of apoptosis: Doubt no more
12. Molecular regulation of apoptosis: Genetic controls on cell death
13. Apoptosis by death factor
14. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor I and Fas(Apo-1/CD95)
15. The receptor for the cytotoxic ligand TRAIL
16. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB
17. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
18. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
19. TRAIL: A molecule with multiple receptors and control mechanisms
20. Apoptosis control by death and decoy receptors
21. Identification and characterization of a new member of the TNF family that induces apoptosis
22. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
23. An antagonist decoy receptor and a death domain-containing receptor TRAIL
24. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
25. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signaling
26. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
27. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
28. Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest
29. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL
30. Type I interferon (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of the type I IFNs
31. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression
32. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells
33. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
34. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
35. Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
36. Fas and FasL in the homeostatic regulation of the immune responses
37. Radiation and stress-induced apoptosis: A role for Fas/Fas ligand interactions
38. Interferon a augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression
39. TRAIL causes cleavage of bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells
40. Apoptosis-induced by TRAIL and TNF-alpha in human multiple myeloma cells is not blocked by BCL-2
41. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis
42. Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis
43. TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria
44. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells
45. Two CD95 (APO-1/Fas) signaling pathways
46. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
47. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is assoicated with downregulation of its proapoptotic activity and loss of liver toxicity
48. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles
49. Functional analysis of TRAIL receptors using monoclonal antibodies
50. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha
51. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
52. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor α
53. Simultaneous production of natural human tumor necrosis factor-α, -β and interferon-α from BALL-1 cells stimulated by HVJ
54. Tyrosine protein kinase is involved in anti-IgM-mediated signaling in BAL17 B lymphoma cells
55. + T cell-mediated cytotoxicity
56. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability
57. Prevention of anti-IgM-induced apoptosis accompanying GI arrest in B lymphoma cells overexpressing dominant-negative mutant form of c-Jun N-terminal kinase 1